tm logo
MAXX BMC
Live/Registered
REGISTERED

on 08 Aug 2023

Last Applicant/ Owned by

401 Hackensack Avenue, Suite 604

Hackensack

NJ

07601

Serial Number

90569171 filed on 09th Mar 2021

Registration Number

7133814 registered on 08th Aug 2023

in the Principal Register

Correspondent Address

David Meibos

David Meibos

6800 NORTH 2400 WEST

AMALGA, UT 84335

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

MAXX BMC

Autologous biomaterial collection, processing, and therapeutic application systems comprised of medical instruments and equipment for the collection, processing and therapeutic application of bone marrow for use in platelet rich plasma therapy for orthopedic, aesthetic and cosmetic purposes only and limited to in-office and operating room use

Classification Information


Class [010]
Medical Instrument Products


Autologous biomaterial collection, processing, and therapeutic application systems comprised of medical instruments and equipment for the collection, processing and therapeutic application of bone marrow for use in platelet rich plasma therapy for orthopedic, aesthetic and cosmetic purposes only and limited to in-office and operating room use


First Use Date in General

23rd Jun 2022

First Use Date in Commerce

23rd Jun 2022

Specimens


MAXX BMC specimen

Mark Details


Serial Number

No 90569171

Mark Type

No Service/Collective Mark

Attorney Docket Number

No RYO-TM12

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Aug 2023REGISTERED-PRINCIPAL REGISTER
08th Aug 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th Jul 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06th Jul 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23rd Jun 2023ASSIGNED TO LIE
23rd Jun 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
23rd Jun 2023TEAS/EMAIL CORRESPONDENCE ENTERED
27th Feb 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
27th Feb 2023STATEMENT OF USE PROCESSING COMPLETE
05th Feb 2023TEAS STATEMENT OF USE RECEIVED